Ealixir Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	0.05	0.11	0.33	0.07
Cash & Short-Term Investments	0.05	0.11	0.33	0.07
Cash Growth	-53.06%	-65.87%	345.19%	-
Accounts Receivable	1.35	1.41	0.82	0.33
Other Receivables	0.08	0.03	0.02	-
Receivables	1.43	1.44	0.85	0.33
Prepaid Expenses	-	-	-	0.03
Other Current Assets	0.27	0.07	0.21	-
Total Current Assets	1.75	1.62	1.39	0.44
Property, Plant & Equipment	0.14	0.24	0.33	0
Other Intangible Assets	0.15	0.08	-	-
Long-Term Deferred Tax Assets	0.69	0.11	0.11	-
Other Long-Term Assets	0	-	0	0.03
Total Assets	2.74	2.05	1.83	0.47
Accounts Payable	0.59	0.39	0.38	0.35
Accrued Expenses	0.93	0.59	0.38	-
Short-Term Debt	0.3	0.28	0.53	-
Current Portion of Leases	0.07	0.07	0.07	-
Current Income Taxes Payable	0.08	0.05	0.26	0.45
Current Unearned Revenue	0.69	0.87	1.02	0.71
Other Current Liabilities	0.02	-	0.16	0.51
Total Current Liabilities	2.69	2.26	2.8	2.02
Long-Term Debt	-	0.3	-	0.14
Long-Term Leases	0.05	0.12	0.19	-
Total Liabilities	2.74	2.67	2.99	2.16
Common Stock	0.06	0.05	0.05	0.04
Additional Paid-In Capital	3.59	1.92	1.54	0.6
Retained Earnings	-3.37	-2.43	-2.68	-2.34
Comprehensive Income & Other	-0.27	-0.17	-0.07	0.01
Total Common Equity	0	-0.63	-1.16	-1.69
Minority Interest	-	0	0	-
Shareholders' Equity	0	-0.63	-1.16	-1.69
Total Liabilities & Equity	2.74	2.05	1.83	0.47
Total Debt	0.42	0.78	0.79	0.14
Net Cash (Debt)	-0.37	-0.66	-0.46	-0.06
Net Cash Per Share	-0.01	-0.01	-0.01	-0.00
Filing Date Shares Outstanding	60.28	48.26	45.6	36.12
Total Common Shares Outstanding	60.28	48.26	45.6	36.12
Working Capital	-0.93	-0.64	-1.41	-1.59
Book Value Per Share	0.00	-0.01	-0.03	-0.05
Tangible Book Value	-0.15	-0.71	-1.16	-1.69
Tangible Book Value Per Share	-0.00	-0.01	-0.03	-0.05
Machinery	0.04	0.06	0.08	0.01

Source: S&P Capital IQ. Standard template. Financial Sources.